Suppr超能文献

促甲状腺素受体刺激自身抗体生物测定法的标准化

Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies.

作者信息

Diana Tanja, Kanitz Michael, Lehmann Markus, Li Yunsheng, Olivo Paul D, Kahaly George J

机构信息

1 Molecular Thyroid Research Laboratory, Johannes Gutenberg University Medical Center , Mainz, Germany .

出版信息

Thyroid. 2015 Feb;25(2):169-75. doi: 10.1089/thy.2014.0346. Epub 2014 Nov 20.

Abstract

BACKGROUND

Cell-based bioassays for functional thyroid stimulating autoantibodies (TSAb) are sensitive diagnostic tools. However, there is no bioassay available that is standardized with international reference material. We aimed to promote the standardization of the test results among laboratories that perform TSAb bioassays and calibrate TSAb levels against the second international standard (IS) 08/204 from the National Institute for Biological Standards and Control (NIBSC).

METHODS

Serum TSAb activity was measured with a FDA-cleared bioassay that utilizes CHO cells expressing a chimeric thyrotropin receptor (TSHR) and a c-AMP response-element-dependent luciferase. The IS was applied for calibration. TSAb results were reported as percentage of specimen-to-reference ratio (SRR%) and converted into mIU/L.

RESULTS

The IS dose-response curve was obtained using concentrations from 0.3125 to 200 mIU/L. Mean TSAb SRR%±standard deviation (SD) values for the IS concentrations 0.3125, 0.625, 1.25, 2.5, 5, 10, 20, 40, 60, 80, 100, 120, 160, and 200 mIU/L were 63±4 (CV 6.3%), 63±4 (6.3), 67±2 (3.0), 76±6 (7.9), 91±8 (8), 134±8 (5.9), 201±13 (6.5), 294±12 (4.1), 336±10 (3.0), 348±8 (2.3), 360±14 (3.8), 371±15 (4.0), 381±9 (2.4), and 389±10 (2.6), respectively. A total of 127 dilution experiments were performed using 12 high TSAb-positive sera from patients with Graves' disease. When diluting TSAb-positive sera, IS concentrations within the linear range 5, 10, 20, 40, and 80 mIU/L were used for the calibration curve. All standard curves had R(2) values >0.95. Low coefficient of variation (CV %) values for the IS calibration curve (4-6%) were obtained. Compared to bovine TSH, no significant differences were noted using either a pool of healthy donors or a normal serum as reference controls. The average IU measured value for the assay cutoff (SRR 140%) corresponded to 9.54±1.68 mIU/L, and clinical application was shown in 60 Graves' patients.

CONCLUSIONS

The TSAb bioassay demonstrated excellent performance in terms of linear range, limit of quantitation, and imprecision. The dilution experiments showed a high correlation coefficient and excellent reproducibility. Thus, TSAb levels can be reliably converted from SRR% to IU/L. These results offer the perspective of standardizing TSAb levels among laboratories and enable more accurate comparison of TSAb studies.

摘要

背景

基于细胞的促甲状腺素刺激性自身抗体(TSAb)生物测定法是敏感的诊断工具。然而,目前尚无使用国际参考物质进行标准化的生物测定法。我们旨在促进进行TSAb生物测定的实验室之间测试结果的标准化,并根据国家生物标准与控制研究所(NIBSC)的第二个国际标准(IS)08/204校准TSAb水平。

方法

使用经美国食品药品监督管理局(FDA)批准的生物测定法测量血清TSAb活性,该方法利用表达嵌合促甲状腺素受体(TSHR)和c-AMP反应元件依赖性荧光素酶的CHO细胞。应用国际标准进行校准。TSAb结果报告为标本与参考比值(SRR%),并转换为mIU/L。

结果

使用0.3125至200 mIU/L的浓度获得了国际标准剂量反应曲线。国际标准浓度0.3125、0.625、1.25、2.5、5、10、20、40、60、80、100、120、160和200 mIU/L的平均TSAb SRR%±标准差(SD)值分别为63±4(CV 6.3%)、63±4(6.3)、67±2(3.0)、76±6(7.9)、91±8(8)、134±8(5.9), 201±13 (6.5), 294±12 (4.1), 336±10 (3.0), 348±8 (2.3), 360±14 (3.8), 371±15 (4.0), 381±9 (2.4), 389±10 (2.6)。使用来自格雷夫斯病患者的12份高TSAb阳性血清进行了总共127次稀释实验。在稀释TSAb阳性血清时,线性范围5、10、20、40和80 mIU/L内的国际标准浓度用于校准曲线。所有标准曲线的R(2)值>0.95。获得了国际标准校准曲线的低变异系数(CV%)值(4-6%)。与牛促甲状腺素相比,使用健康供体池或正常血清作为参考对照均未发现显著差异。该测定临界值(SRR 140%)的平均IU测量值对应于9.54±1.68 mIU/L,并在60例格雷夫斯病患者中展示了临床应用。

结论

TSAb生物测定法在线性范围、定量限和不精密度方面表现出色。稀释实验显示出高相关系数和出色的重现性。因此,TSAb水平可以可靠地从SRR%转换为IU/L。这些结果为实验室间TSAb水平的标准化提供了前景,并能够更准确地比较TSAb研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验